Tuesday, November 27, 2018 2:11:11 PM
Do you know if the company is reaching out to congressmen that had previously voiced support for approving Actipatch and if BIEL is trying to organize political pressure regarding this decision?
Seems like the FDA has a lot to answer for considering they approved a new opiate 1000x stronger than morphine in a rushed and expedited session less than a month ago but can't seem to find the cajonez when approving this side-effect free device.
Wish these 2 examples were printed side by side in the media to illuminate the FDA incompetence in promoting and mismanaging the opioid epidemic.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM